With 21.2% CAGR Healthcare 3D Printing Market to hit USD 2.2 bn by 2024

Global Healthcare 3D Printing Market was valued at USD 578.0 million in 2017 and is expected to witness 21.2% CAGR from 2018 to 2024.

Rising demand for implants customizations during surgical procedures coupled with growing R&D investments should drive healthcare 3D printing market growth. According to the National Center for Biotechnology Information (NCBI) 2014 data, over next ten years nearly USD 1.9 billion is estimated to be disbursed on medical applications of 3D printing. Such growing investment will boost market growth. Healthcare 3D printing technological advancements and application of advanced devices in the field of bioprinting and tissue engineering should contribute to business growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1997

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

  • Stratasys
  • Aprecia Pharmaceuticals
  • Renishaw
  • Aspect Biosystems
  • Solidscape
  • Prodways Group
  • Organovo Holdings, Inc.
  • regenHU Ltd.
  • Cyfuse Biomedical K.K.
  • Digilab, Inc.
  • Luxexcel
  • Nano3D Biosciences
  • TeVido BioDevices, Inc
  • VIVAX BIO / 3D Bioprinting Solutions
  • 3D Biotek, LLC

Medical applications segment held 48.4% revenue share in 2017. Wide-ranging medical applications and availability of 3D printed medical devices such as, external prostheses, instrumentation, and implants will stimulate medical application segmental growth. Additionally, R&D for manufacturing of living organs including, heart and liver will offer immense future growth opportunities.

Biosensors segment is projected to grow at 21.8% CAGR during the forecast timeframe due to escalating demand for integrated smart sensors and Nano sensors, along with availability of implantable minimally invasive devices. Additionally, advances such as sensor system, that delivers point-of-care diagnosis as well as biosensors that can monitor patient condition are developments expected to spur market growth.

Magnetic levitation segment is anticipated to grow at 22.6% during 2018 – 2024. Advantages associated with magnetic levitation include easy reconstruction of in-vitro natural tissue environment and culturing of 3D cultures that have long durability. Aforementioned advantages should boost magnetic levitation segment growth.

Syringe based product segment accounted for 41.1% market share in 2017. Surging use of syringe-based 3D printers in production of varied array of structures used in healthcare will drive segmental growth. Moreover, syringe based offers rapid prototyping that encourages customers to opt for syringe-based products.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1997

U.S. healthcare 3D printing market accounted for 91.1% regional market share in 2017. Advents in technology and presence of leading industry players offering innovative products will augment market growth. Technological advances include blueprint for manufacturing of finger splints that has applications in arthritis, sprains, fractures, jammed fingers and 3D tumor replicas to assist discovery of new anti-cancer drugs.

Healthcare 3D Printing Market By Product

  • Syringe Based
  • Magnetic Levitation
  • Laser Based
  • Inkjet Based

Healthcare 3D Printing Market By Technology

  • Stereolithography (SLA)
  • Fused Deposition Modeling (FDM)
  • Selective Laser Sintering (SLS)